The FDA's Current Position on Peptides Explained Holt Law RFK Jr. promotes peptides. Now the FDA weighs easing limits on the unproven chemicals Regulatory Alert: FDA's April 2026 Update on BPC 157 and GHK Cu Holt Law Stable Gastric Pentadecapeptide BPC 157 as a Therapy and Safety Key: A Special Beneficial Pleiotropic Effect Controlling and Modulating Angiogenesis and the NO System BPC 157 aka Wolverine. This peptide is not FDA approved, but it is very popular among the biohacking population. Ashley explains the science behind it, but remember, it doesn't have human data yet, so